China · Series A startup

Who invested in CMAB Biopharma

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$38Mraised across 1 round since 2017, from 1 source

Latest round
Series A, $38MJan 2017
Investors
3
See who backed them

The rounds

  1. Jan 2017
    Series A$38M

    Reported by FinSMEs

Everyone who backed them

C-Bridge CapitalGrowth equity1round
BioBAY/ I-Bridgeno record of our own yet1round
Qianhai FoFno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about CMAB Biopharma

Who invested in CMAB Biopharma?

CMAB Biopharma's investors include C-Bridge Capital, BioBAY/ I-Bridge and Qianhai FoF.

How much has CMAB Biopharma raised?

CMAB Biopharma has raised $38M across 1 round since 2017.

When did CMAB Biopharma last raise?

CMAB Biopharma's most recent round was a Series A of $38M in Jan 2017.

What was CMAB Biopharma's biggest round?

Its most recent round, $38M in Jan 2017, is also its largest on record.

Who backed CMAB Biopharma first?

CMAB Biopharma's first round on record, in Jan 2017, was backed by C-Bridge Capital, BioBAY/ I-Bridge and Qianhai FoF.

What stage is CMAB Biopharma at?

CMAB Biopharma's latest named round is a Series A, in Jan 2017.

Where is CMAB Biopharma based?

CMAB Biopharma is based in China.

Companies like CMAB Biopharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.